Abstract

BackgroundThe Inflammatory Arthritis (IA) patient population is growing, whilst there already is a shortage of health care professionals (HCPs). It is impossible to meet the future demand for care with...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
POS0588-HPR DISCOVERING THE POTENTIAL OF DIGITAL BIOMARKERS IN THE WORK PROCESS OF THE RHEUMATOLOGY HEALTHCARE PROFESSIONALS, A DESIGN THINKING APPROACH. PRELIMINARY RESULTS OF THE HEALTHCARE PROFESSIONALS PERSPECTIVE
J Luime ... M R Kok
Annals of the Rheumatic Diseases | VOL. 82
J Luime, et. al.J Luime ... M R Kok
30 May 2023
Empathising, defining and ideating with the farming community to develop a geotagged photo app for smart devices: A design thinking approach
Ursula Kenny ... Dave Hearne
Agricultural Systems | VOL. 194
Ursula Kenny, et. al.Ursula Kenny ... Dave Hearne
07 Sep 2021
Customer value development in the light of design thinking approach
Anna Dziadkiewicz
Journal of Positive Management | VOL. 8
Anna DziadkiewiczAnna Dziadkiewicz
05 Jun 2018
Semantic Knowledge Base Ontology Framework for Discovery Stage of the Design Thinking Using Web Ontology Language
A Brahmananda Reddy ... Karnam Akhil
-
A Brahmananda Reddy, et. al.A Brahmananda Reddy ... Karnam Akhil
16 Dec 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers